Heme oxygenase agonists-fluvoxamine, melatonin-are efficacious therapy for Covid-19

被引:5
|
作者
Hooper, Philip L. [1 ]
机构
[1] Univ Colorado Anschutz Med Campus, Dept Med, Div Endocrinol & Metab, Aurora, CO 80045 USA
来源
CELL STRESS & CHAPERONES | 2022年 / 27卷 / 01期
关键词
D O I
10.1007/s12192-021-01246-w
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:3 / 4
页数:2
相关论文
共 50 条
  • [1] Heme oxygenase agonists—fluvoxamine, melatonin—are efficacious therapy for Covid-19
    Philip L. Hooper
    [J]. Cell Stress and Chaperones, 2022, 27 : 3 - 4
  • [2] Fluvoxamine, melatonin and COVID-19
    Anderson, George M.
    [J]. PSYCHOPHARMACOLOGY, 2021, 238 (02) : 611 - 611
  • [3] Fluvoxamine, melatonin and COVID-19
    George M. Anderson
    [J]. Psychopharmacology, 2021, 238 : 611 - 611
  • [4] Fluvoxamine for COVID-19?
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1623): : 69 - 70
  • [5] Fluvoxamine in COVID-19
    Devi, Sharmila
    [J]. LANCET INFECTIOUS DISEASES, 2024, 24 (01): : E23 - E23
  • [6] Fluvoxamine for the treatment of COVID-19
    Marzolini, Catia
    Marra, Fiona
    Boyle, Alison
    Khoo, Saye
    Back, David J.
    [J]. LANCET GLOBAL HEALTH, 2022, 10 (03): : E331 - E331
  • [7] Fluvoxamine for the treatment of COVID-19
    Nyirenda, John L. Z.
    Sofroniou, Mario
    Toews, Ingrid
    Mikolajewska, Agata
    Lehane, Cornelius
    Monsef, Ina
    Abu-taha, Aesha
    Maun, Andy
    Stegemann, Miriam
    Schmucker, Christine
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (09):
  • [8] Trial of fluvoxamine in COVID-19
    Kang, Seema
    [J]. LANCET PSYCHIATRY, 2022, 9 (01): : 17 - 17
  • [9] Heme oxygenase-1 as an important predictor of the severity of COVID-19
    Hara, Yu
    Tsukiji, Jun
    Yabe, Aya
    Onishi, Yoshika
    Hirose, Haruka
    Yamamoto, Masaki
    Kudo, Makoto
    Kaneko, Takeshi
    Ebina, Toshiaki
    [J]. PLOS ONE, 2022, 17 (08):
  • [10] The role of carbon monoxide and heme oxygenase-1 in COVID-19
    Kwong, Kenneth K.
    Chan, Suk-tak
    [J]. TOXICOLOGY REPORTS, 2020, 7 : 1170 - 1171